Kathleen Mehigan
About Kathleen Mehigan
Kathleen Mehigan is the Director of Global Product Quality Early Development at Bristol Myers Squibb, with over 20 years of experience in the biotechnology and pharmaceutical industries.
Company
Kathleen Mehigan is currently working at Bristol Myers Squibb as Director, Global Product Quality Early Development. She initially joined the company as Associate Director, Global Product Quality, from 2019 to 2021. Bristol Myers Squibb is a prominent biopharmaceutical company focused on developing innovative medicines.
Title
Kathleen Mehigan holds the title of Director, Global Product Quality Early Development at Bristol Myers Squibb. Her role involves overseeing the quality of products at early stages of development to ensure they meet global standards.
Professional Background
Kathleen Mehigan has accumulated over 20 years of experience in the biotechnology and pharmaceutical industries. She has previously held significant roles, including Associate Director, Global Product Quality at Juno Therapeutics, Inc., and Quality Engineer IV at Bio-Rad Laboratories. She has also served as Senior Associate Project Manager at Amgen, demonstrating a diverse range of skills across quality control, engineering, and project management.
Expertise in CMC and Quality Control
Kathleen Mehigan has a comprehensive background in CMC (Chemistry, Manufacturing, and Controls) quality and analytics. Her role as Senior Manager, CMC Quality and Analytics at Juno Therapeutics, Inc., exemplifies her expertise in this area. She has also managed quality control systems at Dendreon and contributed significantly to ZymoGenetics' quality control systems.
Education and Experience
Kathleen Mehigan studied at Virginia Tech from 1993 to 1998. Her robust educational background laid the foundation for her extensive career in quality management. She has worked at various notable companies including Human Genome Sciences, ZymoGenetics, and Juno Therapeutics, focusing on quality control, project management, and quality engineering.